| CodeList |
| CodeListItem |
| NCI attributes |
| C165635 | ADaM Basic Data Structure Subclass |
| C165636 | ADaM Integrated Basic Data Structure Subclass |
| C117745 | Analysis Purpose |
| C117744 | Analysis Reason |
| C66788 | Dictionary Name |
| C103329 | General Observation Class |
| OID | Name (CDISC Submission Value) | DataType Extensible | NCI Code | CDISC Synonym | CDISC Definition | Preferred Term |
|---|---|---|---|---|---|---|
| CDISC Submission Value [ODM:CodedValue] | ||||||
| CL.C165635.BDSSC | ADaM Basic Data Structure Subclass (BDSSC) | text Extensible: No | C165635 | ADaM Basic Data Structure Subclass | Terminology relevant to the subclasses of the ADaM basic data structure. | CDISC Define-XML ADaM Basic Data Structure Subclass Terminology |
| TIME-TO-EVENT | C165637 | TTE | A dataset containing data that is used for Time-to-Event analyses. | Time-to-Event Dataset | ||
| Back to top | ||||||
| CL.C165636.BDSISC | ADaM Integrated Basic Data Structure Subclass (BDSISC) | text Extensible: No | C165636 | ADaM Integrated Basic Data Structure Subclass | Purpose of a specific analysis result described in ADaM analysis results metadata. | CDISC Define-XML ADaM Integrated Basic Data Structure Subclass Terminology |
| TIME-TO-EVENT | C165637 | TTE | A dataset containing data that is used for Time-to-Event analyses. | Time-to-Event Dataset | ||
| Back to top | ||||||
| CL.C117745.ANLPURP | Analysis Purpose (ANLPURP) | text Extensible: Yes | C117745 | Analysis Purpose | Purpose of a specific analysis result described in Define-XML analysis results metadata. | CDISC Define-XML Analysis Purpose Terminology |
| EXPLORATORY OUTCOME MEASURE | C98724 | Exploratory Outcome Measure | Exploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study. | Exploratory Outcome Measure | ||
| PRIMARY OUTCOME MEASURE | C98772 | Primary Outcome Measure | The primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s). | Primary Outcome Measure | ||
| SECONDARY OUTCOME MEASURE | C98781 | Secondary Outcome Measure | Secondary measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s). | Secondary Outcome Measure | ||
| Back to top | ||||||
| CL.C117744.ANLREAS | Analysis Reason (ANLREAS) | text Extensible: Yes | C117744 | Analysis Reason | Reason for reporting a specific analysis result described in Define-XML analysis results metadata. | CDISC Define-XML Analysis Reason Terminology |
| DATA DRIVEN | C117750 | The analysis was triggered by findings in the data. | Data Driven Analysis | |||
| REQUESTED BY REGULATORY AGENCY | C117751 | The analysis has been requested by a regulatory agency. | Analysis Requested by Regulatory Agency | |||
| SPECIFIED IN PROTOCOL | C117752 | The analysis is specified in a protocol. | Analysis Specified in Protocol | |||
| SPECIFIED IN SAP | C117753 | The analysis is specified in a statistical analysis plan. | Analysis Specified in Statistical Analysis Plan | |||
| Back to top | ||||||
| CL.C66788.DICTNAM | Dictionary Name (DICTNAM) | text Extensible: Yes | C66788 | Dictionary Name | A name given to a reference source that lists words and gives their meaning. (NCI) | CDISC Dictionary Name Terminology |
| CDISC CT | C163415 | CDISC Controlled Terminology;Clinical Data Interchange Standards Consortium Controlled Terminology | A standard terminology developed and maintained by Clinical Data Interchange Standards Consortium (CDISC) and the National Cancer Institute Enterprise Vocabulary Services (NCI-EVS) to support CDISC models, domains and specifications for data representation in regulated research. | Clinical Data Interchange Standards Consortium Controlled Terminology | ||
| COSTART | C49471 | Coding Symbols for a Thesaurus of Adverse Reaction Terms | A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI) | Thesaurus of Adverse Reaction Term Coding Symbols | ||
| CTCAE | C49704 | Common Terminology Criteria for Adverse Events | A standard terminology developed and maintained by the National Cancer Institute to report adverse events occurring in clinical trials. The CTCAE contains a grading scale for each adverse event term representing the severity of the event. | Common Terminology Criteria for Adverse Events | ||
| D-U-N-S NUMBER | C134003 | DUNS Numbers;Data Universal Number System | A proprietary system developed and regulated by Dun & Bradstreet that assigns a unique nine digit numeric identifier to a single business entity location. | Data Universal Numbering System | ||
| ICD | C49474 | International Classification of Diseases | A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12) | International Classification of Diseases | ||
| LOINC | C49476 | Logical Observation Identifiers Names and Codes | Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI) | Logical Observation Identifiers Names and Codes | ||
| MED-RT | C163416 | Medication Reference Terminology;NDF-RT | A standard terminology developed and maintained by the Veterans Health Administration (VHA) that includes terminology to support the mechanism of action, physiologic effect, and asserted pharmacologic classification relationships of medications. MED-RT incorporates terminology from RxNORM, MeSH, and SNOMED CT. | Medication Reference Terminology | ||
| MedDRA | C43820 | Medical Dictionary for Regulatory Activities | MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI) | MedDRA | ||
| SNOMED | C53489 | Systematized Nomenclature of Medicine | A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI) | Systematized Nomenclature of Medicine | ||
| UNII | C163417 | SRS-UNII;Substance Registration System-Unique Ingredient Identifier | A standard terminology developed and maintained by the Department of Veterans Affairs/Veterans Health Administration designated federal collaborative Structured Product Labeling Interagency Expert Panel (SPLIEP). It contains terminology to support the mechanism of action, physiologic effect, and asserted pharmacologic classification relationships of drug ingredients and food allergens. | Substance Registration System-Unique Ingredient Identifier | ||
| WHO ATC CLASSIFICATION SYSTEM | C154331 | Anatomical Therapeutic Chemical Classification System | A World Health Organization (WHO) classification system, developed and maintained by the WHO Collaborating Centre for Drug Statistics Methodology, for medicinal substances where active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological, and chemical properties. | Anatomical Therapeutic Chemical Classification System | ||
| WHOART | C49468 | World Health Organization Adverse Reaction Terms | A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI) | World Health Organization Adverse Reaction Terminology | ||
| WHODD | C49475 | WHODrug Global;World Health Organization Drug Dictionary | A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI) | World Health Organization Drug Dictionary | ||
| Back to top | ||||||
| CL.C103329.GNRLOBSC | General Observation Class (GNRLOBSC) | text Extensible: No | C103329 | General Observation Class | Terminology related to the classification of a CDISC domain. | CDISC Define-XML General Observation Class Terminology |
| ADAM OTHER | C103375 | An analysis dataset that doesn't conform to a pre-defined ADaM dataset structure (e.g. ADSL, BDS or OCCDS). | CDISC Other ADaM Dataset | |||
| BASIC DATA STRUCTURE | C103371 | BDS | An ADaM BDS dataset contains one or more records per subject, per analysis parameter, per analysis time point. Variables include the value being analyzed (e.g., AVAL) and the description of the value being analyzed (e.g., PARAM). Other variables in the dataset provide more information about the value being analyzed (e.g., the subject identification) or describe and trace the derivation of it (e.g., DTYPE) or support the analysis of it (e.g., treatment variables, covariates). | CDISC Basic Data Structure Dataset | ||
| EVENTS | C103372 | This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). | CDISC Events Class | |||
| FINDINGS | C103373 | This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. | CDISC Findings Class | |||
| FINDINGS ABOUT | C135396 | This SDTM class is a specialization of the findings general observation class. It is intended, as its name implies, to be used when collected data represent findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier to such a record. | CDISC Findings About Class | |||
| INTEGRATED BASIC DATA STRUCTURE | C132357 | IBDS | The Integrated Basic Data Structure is the ADaM data structure including POOL as defined in the integrated SAP. If the IBDS class is needed then IADSL is required. See the study-level BDS class for further details. | CDISC Integrated Basic Data Structure Dataset | ||
| INTEGRATED OCCURRENCE DATA STRUCTURE | C132358 | IOCCDS | The Integrated Occurrence Data Strucutre is the ADaM data structure including POOL as defined in the integrated SAP. If the IOCCDS class is needed then IADSL is required. See the study-level OCCDS class for further details. | CDISC Integrated Occurrence Data Structure Dataset | ||
| INTEGRATED SUBJECT LEVEL | C132359 | IADSL | The Integrated Subject-Level Analysis Dataset is one record per subject per pool as defined in the integrated SAP and allows multiple records per subject. The integrated ADSL dataset, similar to the study-level ADSL dataset, contains variables that describe subject demographic characteristics and group the subjects for analysis, and is the primary source for subject-level variables included in other analysis datasets such as population flags and treatment variables. | CDISC Integrated Subject Level Dataset | ||
| INTERVENTIONS | C103374 | This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). | CDISC Interventions Class | |||
| OCCURRENCE DATA STRUCTURE | C123454 | OCCDS | The Occurrence Data Structure (OCCDS) is the ADaM data structure for occurrence analysis. Occurrence analysis is the counting of subjects with a record or term, and often includes a structured hierarchy of dictionary coding categories. | CDISC Occurrence Data Structure | ||
| RELATIONSHIP | C103376 | This SDTM class provides a means to link related records between datasets. It includes the RELREC and SUPPQUAL datasets. | CDISC Relationship Class | |||
| SPECIAL PURPOSE | C103377 | SPECIAL-PURPOSE | This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. | CDISC Special Purpose Class | ||
| STUDY REFERENCE | C147271 | This special purpose SDTM class contains further descriptions of study-specific identifiers that will be used in subject based domains. | CDISC Study Reference Class | |||
| SUBJECT LEVEL ANALYSIS DATASET | C103378 | ADSL | The Subject-Level Analysis Dataset (ADSL) is a one-record-per-subject dataset which contains variables that describe subject demographic characteristics and group the subjects for analysis. ADSL is the primary source for subject-level variables included in other analysis datasets such as population flags and treatment variables. | CDISC Subject Level Analysis Dataset | ||
| TRIAL DESIGN | C103379 | This SDTM class describes the plan for the procedures to be followed in a clinical trial, including planned and actual timing of events, control group, method of allocating treatments, blinding methods, assignment of epochs that subjects pass through in the course of a trial. | CDISC Trial Design Class | |||
| Back to top | ||||||